Completed Efficacy and Safety of Tegoprazan Dual Therapy and Furazolidone-based Bismuth Quadruple Therapy for Helicobacter Pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study NCT06340334 Conditions Furazolidone, Helicobacter Pylori Infection, Tegoprazan Locations Nanjing First Hospital — Nanjing, China View Trial Details
